» Articles » PMID: 12969988

Endothelial Protection by High-density Lipoproteins: from Bench to Bedside

Overview
Date 2003 Sep 13
PMID 12969988
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

There are several potential mechanisms by which HDLs protect against the development of vascular disease. One relates to the unique ability of these lipoproteins to remove cholesterol from the arterial wall. Another is the ability of HDL to prevent and eventually correct endothelial dysfunction, a key variable in the pathogenesis of atherosclerosis and its complications. HDLs help maintain endothelial integrity, facilitate vascular relaxation, inhibit blood cell adhesion to vascular endothelium, reduce platelet aggregability and coagulation, and may favor fibrinolysis. These functions of HDLs complement their activity in arterial cholesterol removal by providing an excellent rationale for favorably influencing pathological processes underlying a variety of clinical conditions, such as accelerated atherosclerosis, acute coronary syndromes, and restenosis after coronary angioplasty, through a chronic or acute elevation of plasma HDL concentration.

Citing Articles

Dapagliflozin-Induced Myocardial Flow Reserve Improvement is not Associated with HDL Ability to Stimulate Endothelial Nitric Oxide Production.

Capece U, Pavanello C, Cinti F, Leccisotti L, Mezza T, Ciccarelli G Diabetes Ther. 2023; 15(1):257-268.

PMID: 37883003 PMC: 10786750. DOI: 10.1007/s13300-023-01491-5.


Association between monocyte to high-density lipoprotein cholesterol ratio and multi-vessel coronary artery disease: a cross-sectional study.

Chen J, Wu K, Cao W, Shao J, Huang M Lipids Health Dis. 2023; 22(1):121.

PMID: 37553680 PMC: 10408165. DOI: 10.1186/s12944-023-01897-x.


A Current Update on the Role of HDL-Based Nanomedicine in Targeting Macrophages in Cardiovascular Disease.

Rani A, Marsche G Pharmaceutics. 2023; 15(5).

PMID: 37242746 PMC: 10221824. DOI: 10.3390/pharmaceutics15051504.


HDL and chronic kidney disease.

Pavanello C, Ossoli A Atheroscler Plus. 2023; 52:9-17.

PMID: 37193017 PMC: 10182177. DOI: 10.1016/j.athplu.2023.04.001.


HDL-Associated Proteins in Subjects with Polycystic Ovary Syndrome: A Proteomic Study.

Butler A, Moin A, Reiner Z, Sathyapalan T, Jamialahmadi T, Sahebkar A Cells. 2023; 12(6).

PMID: 36980195 PMC: 10047209. DOI: 10.3390/cells12060855.